Filing Details
- Accession Number:
- 0001093557-20-000093
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-13 21:17:02
- Reporting Period:
- 2020-03-11
- Accepted Time:
- 2020-03-13 21:17:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1286858 | R Kevin Sayer | 6340 Sequence Drive San Diego CA 92121 | President, Ceo And Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-03-11 | 8 | $246.27 | 210,382 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-03-11 | 796 | $250.09 | 209,586 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-03-11 | 19,570 | $265.43 | 190,016 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-03-12 | 13,474 | $0.00 | 176,542 | No | 4 | G | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | G | Direct |
Footnotes
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- This transaction was executed in multiple trades at prices ranging from $246.1339 to $246.36. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- Included in this number are 76,187 unvested restricted stock units, 25,453 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 23,886 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 26,848 of which were granted on March 8, 2018 and shall vest through March 8, 2021.
- This transaction was executed in multiple trades at prices ranging from $250.02 to $250.152. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- The transaction represents a gift by the Reporting Person of 13,474 shares to a charitable donor advised fund.
Billionaire Hedge Funds
